Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Oct;151(4):1153–1161.

Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker.

M L Larramendy 1, M Tarkkanen 1, C Blomqvist 1, M Virolainen 1, T Wiklund 1, S Asko-Seljavaara 1, I Elomaa 1, S Knuutila 1
PMCID: PMC1858055  PMID: 9327749

Abstract

DNA sequence copy number changes were studied by comparative genomic hybridization (CGH) along all chromosomes in 58 samples of malignant fibrous histiocytoma (MFH). The material consisted of 43 primary tumors (9 of myxoid and 34 of storiform-pleomorphic subtype), 13 local recurrences (2 myxoid and 11 storiform-pleomorphic), and 2 metastases (1 myxoid and 1 storiform-pleomorphic). Genetic aberrations, with a mean of 5.5 changes per sample (range, 0 to 22), were detected in 47 of 58 samples (81%). The minimal common regions of the most frequent gains were 1p31 (33%), 9q31 (29%), 5p14-pter (26%), 7q32 (24%), and 7p15-pter (22%). High-level amplifications were detected in 16 of the 58 samples (28%). High-level amplification of 13q31-qter was seen in four tumors (7%); other high-level amplifications were more sporadic. Losses of DNA sequences were less frequent than gains. The minimal common regions of the most common losses were 13q21 (21%) and 13q22 (21%). Statistically significant correlation was found between gain of 7q32 and the rates of worse metastasis-free survival (P = 0.01) and overall survival (P = 0.004). The gain of 7q32 retained its prognostic significance also in a multivariate analysis with tumor size and grade. Gain of 1p31 was associated with a trend to decreased overall survival. Gains of 5p14-pter and 9q31 and losses of 13q21 and/or 13q22 did not have any prognostic value; neither did the total number of aberrations, total number of gains, or total number of losses per sample.

Full text

PDF
1153

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cheng J. Q., Jhanwar S. C., Klein W. M., Bell D. W., Lee W. C., Altomare D. A., Nobori T., Olopade O. I., Buckler A. J., Testa J. R. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res. 1994 Nov 1;54(21):5547–5551. [PubMed] [Google Scholar]
  2. Choong P. F., Mandahl N., Mertens F., Willén H., Alvegård T., Kreicbergs A., Mitelman F., Rydholm A. 19p+ marker chromosome correlates with relapse in malignant fibrous histiocytoma. Genes Chromosomes Cancer. 1996 Jun;16(2):88–93. doi: 10.1002/(SICI)1098-2264(199606)16:2<88::AID-GCC2>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  3. Forus A., Weghuis D. O., Smeets D., Fodstad O., Myklebost O., van Kessel A. G. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer. 1995 Sep;14(1):8–14. doi: 10.1002/gcc.2870140103. [DOI] [PubMed] [Google Scholar]
  4. Friend S. H., Horowitz J. M., Gerber M. R., Wang X. F., Bogenmann E., Li F. P., Weinberg R. A. Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9059–9063. doi: 10.1073/pnas.84.24.9059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gordon K. B., Thompson C. T., Char D. H., O'Brien J. M., Kroll S., Ghazvini S., Gray J. W. Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res. 1994 Sep 1;54(17):4764–4768. [PubMed] [Google Scholar]
  6. Gustafson P. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl. 1994 Jun;259:1–31. [PubMed] [Google Scholar]
  7. Hashimoto H., Daimaru Y., Takeshita S., Tsuneyoshi M., Enjoji M. Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer. 1992 Dec 15;70(12):2816–2822. doi: 10.1002/1097-0142(19921215)70:12<2816::aid-cncr2820701215>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  8. Isola J. J., Kallioniemi O. P., Chu L. W., Fuqua S. A., Hilsenbeck S. G., Osborne C. K., Waldman F. M. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol. 1995 Oct;147(4):905–911. [PMC free article] [PubMed] [Google Scholar]
  9. Iwabuchi H., Sakamoto M., Sakunaga H., Ma Y. Y., Carcangiu M. L., Pinkel D., Yang-Feng T. L., Gray J. W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 1995 Dec 15;55(24):6172–6180. [PubMed] [Google Scholar]
  10. Jankowski S. A., Mitchell D. S., Smith S. H., Trent J. M., Meltzer P. S. SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. Oncogene. 1994 Apr;9(4):1205–1211. [PubMed] [Google Scholar]
  11. Joos S., Bergerheim U. S., Pan Y., Matsuyama H., Bentz M., du Manoir S., Lichter P. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer. 1995 Dec;14(4):267–276. doi: 10.1002/gcc.2870140405. [DOI] [PubMed] [Google Scholar]
  12. Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stockert E., Day R. S., 3rd, Johnson B. E., Skolnick M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994 Apr 15;264(5157):436–440. doi: 10.1126/science.8153634. [DOI] [PubMed] [Google Scholar]
  13. Kim D. H., Mohapatra G., Bollen A., Waldman F. M., Feuerstein B. G. Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer. 1995 Mar 16;60(6):812–819. doi: 10.1002/ijc.2910600615. [DOI] [PubMed] [Google Scholar]
  14. Larramendy M. L., Tarkkanen M., Valle J., Kivioja A. H., Ervasti H., Karaharju E., Salmivalli T., Elomaa I., Knuutila S. Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas. Am J Pathol. 1997 Feb;150(2):685–691. [PMC free article] [PubMed] [Google Scholar]
  15. Le Doussal V., Coindre J. M., Leroux A., Hacene K., Terrier P., Bui N. B., Bonichon F., Collin F., Mandard A. M., Contesso G. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. Cancer. 1996 May 1;77(9):1823–1830. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1823::AID-CNCR10>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  16. Mandahl N. Cytogenetics and molecular genetics of bone and soft tissue tumors. Adv Cancer Res. 1996;69:63–99. doi: 10.1016/s0065-230x(08)60860-x. [DOI] [PubMed] [Google Scholar]
  17. Mandahl N., Heim S., Arheden K., Rydholm A., Willén H., Mitelman F. Rings, dicentrics, and telomeric association in histiocytomas. Cancer Genet Cytogenet. 1988 Jan;30(1):23–33. doi: 10.1016/0165-4608(88)90089-1. [DOI] [PubMed] [Google Scholar]
  18. Mandahl N., Heim S., Willén H., Rydholm A., Eneroth M., Nilbert M., Kreicbergs A., Mitelman F. Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma. Genes Chromosomes Cancer. 1989 Sep;1(1):9–14. doi: 10.1002/gcc.2870010104. [DOI] [PubMed] [Google Scholar]
  19. Markhede G., Angervall L., Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer. 1982 Apr 15;49(8):1721–1733. doi: 10.1002/1097-0142(19820415)49:8<1721::aid-cncr2820490832>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  20. Meltzer P. S., Jankowski S. A., Dal Cin P., Sandberg A. A., Paz I. B., Coccia M. A. Identification and cloning of a novel amplified DNA sequence in human malignant fibrous histiocytoma derived from a region of chromosome 12 frequently rearranged in soft tissue tumors. Cell Growth Differ. 1991 Oct;2(10):495–501. [PubMed] [Google Scholar]
  21. Moch H., Presti J. C., Jr, Sauter G., Buchholz N., Jordan P., Mihatsch M. J., Waldman F. M. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res. 1996 Jan 1;56(1):27–30. [PubMed] [Google Scholar]
  22. Monni O., Joensuu H., Franssila K., Klefstrom J., Alitalo K., Knuutila S. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood. 1997 Aug 1;90(3):1168–1174. [PubMed] [Google Scholar]
  23. Nilbert M., Mandahl N., Aman P., Rydholm A., Mitelman F. No rearrangements of the CHOP gene in malignant fibrous histiocytoma. Cancer Genet Cytogenet. 1994 Feb;72(2):155–156. doi: 10.1016/0165-4608(94)90133-3. [DOI] [PubMed] [Google Scholar]
  24. Nilbert M., Rydholm A., Mitelman F., Meltzer P. S., Mandahl N. Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet. 1995 Aug;83(1):32–36. doi: 10.1016/s0165-4608(95)00016-x. [DOI] [PubMed] [Google Scholar]
  25. Nilbert M., Rydholm A., Willén H., Mitelman F., Mandahl N. MDM2 gene amplification correlates with ring chromosome in soft tissue tumors. Genes Chromosomes Cancer. 1994 Apr;9(4):261–265. doi: 10.1002/gcc.2870090406. [DOI] [PubMed] [Google Scholar]
  26. Nobori T., Miura K., Wu D. J., Lois A., Takabayashi K., Carson D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994 Apr 21;368(6473):753–756. doi: 10.1038/368753a0. [DOI] [PubMed] [Google Scholar]
  27. Pezzi C. M., Rawlings M. S., Jr, Esgro J. J., Pollock R. E., Romsdahl M. M. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer. 1992 Apr 15;69(8):2098–2103. doi: 10.1002/1097-0142(19920415)69:8<2098::aid-cncr2820690815>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  28. Prescher G., Bornfeld N., Hirche H., Horsthemke B., Jöckel K. H., Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996 May 4;347(9010):1222–1225. doi: 10.1016/s0140-6736(96)90736-9. [DOI] [PubMed] [Google Scholar]
  29. Ried T., Knutzen R., Steinbeck R., Blegen H., Schröck E., Heselmeyer K., du Manoir S., Auer G. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer. 1996 Apr;15(4):234–245. doi: 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  30. Ried T., Petersen I., Holtgreve-Grez H., Speicher M. R., Schröck E., du Manoir S., Cremer T. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 1994 Apr 1;54(7):1801–1806. [PubMed] [Google Scholar]
  31. Rydholm A., Mandahl N., Heim S., Kreicbergs A., Willén H., Mitelman F. Malignant fibrous histiocytomas with a 19p+ marker chromosome have increased relapse rate. Genes Chromosomes Cancer. 1990 Nov;2(4):296–299. doi: 10.1002/gcc.2870020407. [DOI] [PubMed] [Google Scholar]
  32. Röser B., Willén H., Gustafson P., Alvegård T. A., Rydholm A. Malignant fibrous histiocytoma of soft tissue. A population-based epidemiologic and prognostic study of 137 patients. Cancer. 1991 Jan 15;67(2):499–505. doi: 10.1002/1097-0142(19910115)67:2<499::aid-cncr2820670230>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  33. Schlegel J., Stumm G., Scherthan H., Bocker T., Zirngibl H., Rüschoff J., Hofstädter F. Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res. 1995 Dec 15;55(24):6002–6005. [PubMed] [Google Scholar]
  34. Schröck E., Thiel G., Lozanova T., du Manoir S., Meffert M. C., Jauch A., Speicher M. R., Nürnberg P., Vogel S., Jänisch W. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol. 1994 Jun;144(6):1203–1218. [PMC free article] [PubMed] [Google Scholar]
  35. Smith S. H., Weiss S. W., Jankowski S. A., Coccia M. A., Meltzer P. S. SAS amplification in soft tissue sarcomas. Cancer Res. 1992 Jul 1;52(13):3746–3749. [PubMed] [Google Scholar]
  36. Speicher M. R., Howe C., Crotty P., du Manoir S., Costa J., Ward D. C. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res. 1995 Mar 1;55(5):1010–1013. [PubMed] [Google Scholar]
  37. Szymanska J., Mandahl N., Mertens F., Tarkkanen M., Karaharju E., Knuutila S. Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: a combined cytogenetic and comparative genomic hybridization study. Genes Chromosomes Cancer. 1996 May;16(1):31–34. doi: 10.1002/(SICI)1098-2264(199605)16:1<31::AID-GCC4>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  38. Szymanska J., Tarkkanen M., Wiklund T., Virolainen M., Blomqvist C., Asko-Seljavaara S., Tukiainen E., Elomaa I., Knuutila S. A cytogenetic study of malignant fibrous histiocytoma. Cancer Genet Cytogenet. 1995 Dec;85(2):91–96. doi: 10.1016/0165-4608(95)00143-3. [DOI] [PubMed] [Google Scholar]
  39. Szymanska J., Tarkkanen M., Wiklund T., Virolainen M., Blomqvist C., Asko-Seljavaara S., Tukiainen E., Elomaa I., Knuutila S. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer. 1996 Feb;15(2):89–94. doi: 10.1002/(SICI)1098-2264(199602)15:2<89::AID-GCC2>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
  40. Tarkkanen M., Karhu R., Kallioniemi A., Elomaa I., Kivioja A. H., Nevalainen J., Böhling T., Karaharju E., Hyytinen E., Knuutila S. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res. 1995 Mar 15;55(6):1334–1338. [PubMed] [Google Scholar]
  41. Wadayama B., Toguchida J., Yamaguchi T., Sasaki M. S., Yamamuro T. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer. 1993 Dec;68(6):1134–1139. doi: 10.1038/bjc.1993.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Weber-Hall S., Anderson J., McManus A., Abe S., Nojima T., Pinkerton R., Pritchard-Jones K., Shipley J. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res. 1996 Jul 15;56(14):3220–3224. [PubMed] [Google Scholar]
  43. Wiklund T., Huuhtanen R., Blomqvist C., Tukiainen E., Virolainen M., Virkkunen P., Asko-Seljavaara S., Björkenheim J. M., Elomaa I. The importance of a multidisciplinary group in the treatment of soft tissue sarcomas. Eur J Cancer. 1996 Feb;32A(2):269–273. doi: 10.1016/0959-8049(95)00520-x. [DOI] [PubMed] [Google Scholar]
  44. Wolf M., Aaltonen L. A., Szymanska J., Tarkkanen M., Blomqvist C., Berner J. M., Myklebost O., Knuutila S. Complexity of 12q13-22 amplicon in liposarcoma: microsatellite repeat analysis. Genes Chromosomes Cancer. 1997 Jan;18(1):66–70. doi: 10.1002/(sici)1098-2264(199701)18:1<66::aid-gcc8>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  45. Wunder J. S., Czitrom A. A., Kandel R., Andrulis I. L. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst. 1991 Feb 6;83(3):194–200. doi: 10.1093/jnci/83.3.194. [DOI] [PubMed] [Google Scholar]
  46. Zagars G. K., Mullen J. R., Pollack A. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):983–994. doi: 10.1016/0360-3016(95)02262-7. [DOI] [PubMed] [Google Scholar]
  47. el-Rifai W., Sarlomo-Rikala M., Miettinen M., Knuutila S., Andersson L. C. DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors. Cancer Res. 1996 Jul 15;56(14):3230–3233. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES